Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy

doi:10.3748/wjg.v28.i6.635

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6468)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

392

WORD

187

HTML

3077

Figures (1-7)

353

Tables (1-1)

304

Sum=4313

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

223

Download

446

Sum=669

Publishing Process of This Article

Item

Count

Browse

378

Download

1108

Sum=1486

Feb 14, 2022 (publication date) through Aug 29, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 14, 2022; 28(6): 635-652
Published online Feb 14, 2022. doi: 10.3748/wjg.v28.i6.635

Full Size Figure Download Figure

Figure 2 Cluster analysis (A) and principal coordinate analysis showing that samples do not separate into two groups depending on their condition (0-24 wk) (B).

Citation: Russo E, Nannini G, Sterrantino G, Kiros ST, Di Pilato V, Coppi M, Baldi S, Niccolai E, Ricci F, Ramazzotti M, Pallecchi M, Lagi F, Rossolini GM, Bartoloni A, Bartolucci G, Amedei A. Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy. World J Gastroenterol 2022; 28(6): 635-652
URL: https://www.wjgnet.com/1007-9327/full/v28/i6/635.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i6.635